STE STERIS plc (Ireland) Ordinary Shares
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 7, 2026STE Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
STE Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 25 sierpnia 1998 | 2-for-1 | Naprzód |
| 25 sierpnia 1995 | 2-for-1 | Naprzód |
O STERIS plc (Ireland) Ordinary Shares Przegląd firmy z Wikipedii
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.
Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the president and CEO is Daniel A. Carestio.
## History
Steris was founded in August 1985 in Ohio, under the name "Innovative Medical Technologies".
In 2012, Steris acquired US Endoscopy for $270 million. Steris also acquired Spectrum Surgical Instruments Corp. and Total Repair Express for $110 million combined.
On April 1, 2014, Steris announced its acquisition of Integrated Medical Systems International Inc. for ~$175 million, although it would only cost the company ~$140 million after tax benefits. Shortly after, Steris also acquired Chesterfield, Missouri-based Life Systems.
In October 2014, Steris executed a tax inversion from the United States to the United Kingdom, via an offer made to acquire UK-based Synergy Health for $1.9 billion. The tax inversion was notable as it was the first US inversion post the new rules introduced by the Obama administration in 2014 to curb US corporations moving their "legal domicile" to reduce their exposure to US corporate taxation.
On June 24, 2015, Steris announced the acquisitions of General Econopak for $175 million and Black Diamond Video for $51 million.
Steris filed accounts which showed global revenues of over US$2.6 billion in 2018, of which US$1.8 billion (or 70 percent) came from the US healthcare system; and employed ~12,000 people.
In November 2018, Steris announced that it would further re-domicile its legal headquarters from the United Kingdom to Ireland; Steris had reduced its corporate tax rate from 31.3 percent to 20 percent as a result of its 2014 tax inversion to the United Kingdom, however, it believed a further reduction could be achieved by moving to Ireland.
In April 2020, Steris received emergency use authorization from the FDA for a N95 mask sterilization system to help address the shortage of personal protective equipment during the 2019-20 coronavirus pandemic.
In November 2020, Steris acquired Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products.
In June 2021, Steris acquired Cantel Medical Corporation a provider of infection prevention products and services to endoscopy, dental and dialysis.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | STE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E | 26.3średnia z 5 lat ≈79.9 | ≈79.9 | · | · | |
| P/S (TTM) | 3.4średnia z 5 lat ≈4.4 | ≈4.4 | · | · | |
| P/B (MRQ) | 2.8średnia z 5 lat ≈3.3 | ≈3.3 | · | · | |
| Cena / FCF (TTM) | 22.0średnia z 5 lat ≈39.2 | ≈39.2 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 15.8średnia z 5 lat ≈23.7 | ≈23.7 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 3.6średnia z 5 lat ≈100.9 | ≈100.9 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈2.3 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | STE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 44.4%średnia z 5 lat ≈43.8% | ≈43.8% | · | · | |
| Marża Operacyjna (TTM) | 18.9%średnia z 5 lat ≈13.1% | ≈13.1% | · | · | |
| Marża EBITDA (TTM) | 27.0%średnia z 5 lat ≈23.3% | ≈23.3% | · | · | |
| Marża przed opodatkowaniem (TTM) | 18.0%średnia z 5 lat ≈11.2% | ≈11.2% | · | · | |
| Marża Zysku Netto (TTM) | 13.3%średnia z 5 lat ≈7.9% | ≈7.9% | · | · | |
| ROA | 7.5%średnia z 5 lat ≈4.1% | ≈4.1% | · | · | |
| ROE | 11.3%średnia z 5 lat ≈6.7% | ≈6.7% | · | · | |
| ROIC | 9.1%średnia z 5 lat ≈5.8% | ≈5.8% | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | STE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.3średnia z 5 lat ≈0.4 | ≈0.4 | · | · | |
| Wskaźnik bieżący (MRQ) | 1.9średnia z 5 lat ≈2.3 | ≈2.3 | · | · | |
| Quick Ratio (Wskaźnik Szybkości) | 1.0średnia z 5 lat ≈1.0 | ≈1.0 | · | · | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.2średnia z 5 lat ≈0.4 | ≈0.4 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | STE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 8.7%średnia z 5 lat ≈14.3% | ≈14.3% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 9.4%średnia z 5 lat ≈12.2% | ≈12.2% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 13.8% | · | · | · | |
| EPS YoY | 27.9%średnia z 5 lat ≈48.7% | ≈48.7% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 27.3%średnia z 5 lat ≈49.7% | ≈49.7% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 95.0%średnia z 5 lat ≈41.5% | ≈41.5% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 11.4% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 94.1%średnia z 5 lat ≈42.8% | ≈42.8% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 14.5% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | STE | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.6średnia z 5 lat ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover (Rotacja zapasów) | 5.5średnia z 5 lat ≈5.0 | ≈5.0 | · | · | |
| Receivables Turnover (Rotacja należności) | 5.6średnia z 5 lat ≈5.7 | ≈5.7 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$330.9K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 4, 2026 | $0,69 | USD | ≈0.87% |
| Cze 8, 2026 | $0,63 | USD | ≈0.90% |
| Lut 17, 2026 | $0,63 | USD | ≈0.75% |
| Wrz 4, 2025 | $0,63 | USD | ≈0.96% |
| Cze 10, 2025 | $0,57 | USD | ≈0.94% |
| Lut 20, 2025 | $0,57 | USD | ≈1.0% |
| Lis 19, 2024 | $0,57 | USD | ≈1.0% |
| Wrz 5, 2024 | $0,57 | USD | ≈0.89% |
| Cze 12, 2024 | $0,52 | USD | ≈0.92% |
| Lut 22, 2024 | $0,52 | USD | ≈0.86% |
| Lis 20, 2023 | $0,52 | USD | ≈0.99% |
| Wrz 5, 2023 | $0,52 | USD | ≈0.86% |
| Cze 13, 2023 | $0,47 | USD | ≈0.91% |
| Lut 23, 2023 | $0,47 | USD | ≈0.98% |
| Lis 21, 2022 | $0,47 | USD | ≈1.0% |
| Wrz 6, 2022 | $0,47 | USD | ≈0.89% |
| Cze 13, 2022 | $0,43 | USD | ≈0.81% |
| Lut 24, 2022 | $0,43 | USD | ≈0.74% |
| Lis 22, 2021 | $0,43 | USD | ≈0.72% |
| Wrz 2, 2021 | $0,43 | USD | ≈0.75% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | $2.59 | $2.53 | 2.5% | |
| 31 marca 2026 | $2.83 | $2.88 | -1.6% | |
| 31 grudnia 2025 | $2.53 | $2.56 | -1.1% | |
| 30 września 2025 | $2.47 | $2.37 | 4.0% | |
| 30 czerwca 2025 | $2.34 | $2.29 | 2.4% | |
| 31 marca 2025 | $2.74 | $2.62 | 4.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | $2.62B | $2.61B | |
| Cost of Revenue | $3.31B | $3.06B | $2.92B | $2.56B | $2.34B | $1.76B | $1.71B | $1.61B | $1.53B | $1.59B | |
| Gross Profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B | $1.34B | $1.32B | $1.17B | $1.09B | $1.03B | |
| R&D Expense | $113M | $108M | $104M | $98M | $87M | $66M | $66M | $63M | $61M | $59M | |
| SG&A Expense | $1.41B | $1.33B | $1.25B | $1.09B | $1.32B | $731M | $717M | $670M | $632M | $682M | |
| Operating Expenses | $1.52B | $1.54B | $1.38B | $1.19B | $1.41B | $795M | $783M | $764M | $693M | $800M | |
| Operating Income | $1.10B | $867M | $836M | $791M | $478M | $548M | $537M | $411M | $400M | $226M | |
| Interest Expense | · | · | $144M | $108M | $89M | $37M | $40M | $45M | $51M | $45M | |
| Other Non-op | $10M | $8M | $11M | $-3M | $6M | $6M | $2M | $3M | $6M | $3M | |
| Pretax Income | $1.05B | $796M | $703M | $680M | $367M | $518M | $499M | $369M | $355M | $185M | |
| Income Tax | $262M | $185M | $150M | $124M | $82M | $121M | $91M | $64M | $63M | $74M | |
| Net Income | $782M | $615M | $378M | $107M | $244M | $397M | $408M | $304M | $291M | $110M | |
| EPS (Basic) | $7.97 | $6.24 | $3.83 | $1.07 | $2.50 | $4.66 | $4.81 | $3.59 | $3.42 | $1.29 | |
| EPS (Diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | $3.39 | $1.28 | |
| Shares (Basic) | 98,200,000 | 98,600,000 | 98,800,000 | 99,706,000 | 97,535,000 | 85,203,000 | 84,778,000 | 84,577,000 | 85,028,000 | 85,473,000 | |
| Shares (Diluted) | 98,700,000 | 99,100,000 | 99,400,000 | 100,246,000 | 98,326,000 | 85,898,000 | 85,641,000 | 85,468,000 | 85,713,000 | 86,094,000 | |
| EBITDA | $1.59B | $1.34B | $1.40B | $821M | $979M | $768M | $734M | $637M | · | · |
Bilans
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $440M | $172M | $207M | $208M | $348M | $221M | $320M | $221M | $202M | $283M | |
| Receivables | $1.09B | $1.04B | $1.01B | $865M | $799M | $609M | $586M | $565M | $528M | · | |
| Inventory | $632M | $581M | $675M | $604M | $575M | $315M | $264M | $208M | $206M | · | |
| Current Assets | $2.39B | $2.00B | $2.87B | $2.01B | $1.88B | $1.21B | $1.22B | $1.05B | $990M | · | |
| PP&E (Net) | $2.16B | $1.96B | $1.77B | $1.63B | $1.55B | $1.24B | $1.11B | $1.03B | $1.01B | · | |
| PP&E (Gross) | $4.11B | $3.69B | $3.34B | $3.05B | $2.82B | $2.39B | $2.13B | $1.99B | $1.85B | · | |
| Accum. Depreciation | $1.94B | $1.73B | $1.57B | $1.41B | $1.27B | $1.15B | $1.02B | $956M | $841M | · | |
| Goodwill | $4.19B | $4.10B | $4.07B | $3.88B | $3.94B | $3.03B | $2.36B | $2.32B | $2.43B | $2.23B | |
| Intangibles | $1.62B | $1.85B | $2.12B | $2.08B | $3.33B | $898M | $565M | $605M | $727M | · | |
| Other Non-current Assets | $211M | $83M | $66M | $78M | $71M | $53M | $52M | $60M | $39M | · | |
| Total Assets | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B | $6.57B | $5.44B | $5.07B | $5.20B | · | |
| Accounts Payable | $339M | $281M | $252M | $264M | $226M | $157M | $149M | $153M | $136M | · | |
| Accrued Liabilities | $402M | $368M | $320M | $298M | $307M | $221M | $192M | $188M | $168M | · | |
| Short-term Debt | $119M | $125M | $86M | $60M | $143M | $0 | $0 | · | · | · | |
| Current Liabilities | $1.15B | $1.02B | $931M | $862M | $922M | $578M | $504M | $465M | $398M | · | |
| Capital Leases | $120M | $125M | $146M | $140M | $155M | $130M | $114M | $0 | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $151M | $160M | · | |
| Other Non-current Liabilities | $72M | $62M | $72M | $76M | $76M | $88M | $90M | $88M | $109M | · | |
| Total Liabilities | $3.54B | $3.53B | $4.75B | $4.73B | $4.88B | $2.68B | $2.02B | $1.89B | $1.98B | · | |
| Long-term Debt | $1.81B | $1.92B | $3.12B | $3.02B | $2.95B | $1.65B | $1.15B | $1.18B | $1.32B | · | |
| Total Debt | $1.93B | $2.04B | $3.21B | $3.08B | $3.09B | $1.65B | $1.15B | $1.18B | · | · | |
| Common Stock | $4.28B | $4.42B | $4.54B | $4.49B | $4.74B | $2.00B | $1.98B | $2.00B | $2.05B | · | |
| Retained Earnings | $3.02B | $2.48B | $2.09B | $1.91B | $2.00B | $1.94B | $1.66B | $1.34B | $1.15B | · | |
| AOCI | $-113M | $-292M | $-329M | $-321M | $-210M | $-61M | $-235M | $-160M | $12M | $-241M | |
| Stockholders' Equity | $7.18B | $6.60B | $6.30B | $6.08B | $6.53B | $3.88B | $3.41B | $3.18B | $3.21B | · | |
| Liabilities + Equity | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B | $6.57B | $5.44B | $5.07B | $5.20B | · | |
| Shares Outstanding | 97,800,000 | 98,300,000 | 98,900,000 | 98,600,000 | 100,067,000 | 85,353,000 | 84,924,000 | 84,517,000 | 84,747,000 | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $486M | $476M | $565M | $553M | $553M | $219M | $197M | $226M | $178M | $188M | |
| Stock-based Comp | $62M | $57M | $56M | $39M | $58M | $26M | $24M | $24M | $22M | $19M | |
| Deferred Tax | $-17M | $-76M | $-131M | $-186M | $-107M | $4M | $9M | $-7M | $-25M | $31M | |
| Amort. of Intangibles | $268M | $276M | $268M | $260M | $265M | $87M | $75M | $99M | $70M | $69M | |
| Restructuring | $3M | $62M | $44M | $485.0K | $48.0K | $-3M | $3M | $41M | $103.0K | $215.0K | |
| Other Non-cash | $28M | $76M | $105M | $244M | $-63M | $43M | $-48M | $-8M | · | · | |
| Operating Cash Flow | $1.34B | $1.15B | $973M | $757M | $685M | $690M | $591M | $540M | $458M | $424M | |
| CapEx | $369M | $370M | $360M | $362M | $288M | $239M | $215M | $190M | $165M | $173M | |
| Investing Cash Flow | $-512M | $389M | $-887M | $-383M | $-667M | $-1.15B | $-320M | $-213M | $-204M | $-104M | |
| Net Debt Issued | · | · | · | · | · | $-35M | $0 | $-85M | · | · | |
| Stock Repurchased | $236M | $211M | $12M | $309M | $56M | $15M | $51M | $81M | $65M | $98M | |
| Net Stock Activity | $-236M | $-211M | $-12M | $-309M | $-56M | $-15M | $-51M | $-81M | · | · | |
| Dividends Paid | $242M | $220M | $201M | $183M | $163M | $134M | $123M | $113M | $103M | $93M | |
| Financing Cash Flow | $-568M | $-1.57B | $-85M | $-499M | $116M | $346M | $-163M | $-295M | $-356M | $-267M | |
| Net Change in Cash | $268M | $-35M | $-1M | $-140M | $128M | $-99M | $99M | $19M | $-81M | $34M | |
| Taxes Paid | $289M | $274M | $271M | $255M | $138M | $110M | $92M | $65M | $86M | $78M | |
| Free Cash Flow | $972M | $778M | $613M | $395M | $397M | $450M | $376M | $350M | · | · | |
| Levered FCF | · | · | $499M | $322M | $328M | $422M | $343M | $313M | · | · |
Rentowność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2% | 44.0% | 43.2% | 43.6% | 44.0% | 43.2% | 43.5% | 42.2% | · | · | |
| Operating Margin | 18.6% | 15.9% | 16.3% | 5.4% | 9.3% | 17.6% | 17.7% | 14.8% | · | · | |
| Net Margin | 13.2% | 11.3% | 7.4% | 2.2% | 5.3% | 12.8% | 13.5% | 10.9% | · | · | |
| Pretax Margin | 17.6% | 14.6% | 13.7% | 3.2% | 6.9% | 16.7% | 16.4% | 13.3% | · | · | |
| EBITDA Margin | 26.8% | 24.6% | 27.3% | 16.6% | 21.3% | 24.7% | 24.2% | 22.9% | · | · | |
| ROA | 7.5% | 5.8% | 3.5% | 0.96% | 2.7% | 6.6% | 7.8% | 5.9% | · | · | |
| ROE | 11.3% | 9.5% | 6.1% | 1.7% | 4.7% | 10.9% | 12.4% | 9.5% | · | · | |
| ROIC | 9.1% | 7.7% | 6.9% | 2.0% | 3.4% | 7.6% | 9.7% | 7.8% | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.0 | 3.1 | 2.3 | 2.0 | 2.1 | 2.4 | 2.3 | · | · | |
| Quick Ratio | 1.0 | 1.0 | 1.1 | 1.1 | 0.9 | 1.4 | 1.8 | 1.7 | · | · | |
| Debt / Equity | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | · | · | |
| LT Debt / Equity | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | · | · | |
| Interest Coverage | · | · | 5.8 | 2.5 | 4.8 | 14.7 | 13.3 | 9.1 | · | · |
Efektywność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | · | · | |
| Inventory Turnover | 5.5 | 4.9 | 4.6 | 4.4 | 5.8 | 6.1 | 7.5 | 7.8 | · | · | |
| Receivables Turnover | 5.6 | 5.3 | 5.5 | 5.7 | 6.5 | 5.2 | 5.3 | 5.1 | · | · |
Na akcję
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $73.45 | $67.18 | $63.73 | $61.62 | $65.28 | $45.47 | $39.96 | $37.60 | · | · | |
| Revenue / Share | $60.14 | $55.11 | $51.72 | $49.46 | $46.63 | $36.18 | $35.39 | $32.55 | · | · | |
| Cash Flow / Share | $13.59 | $11.59 | $9.80 | $7.55 | $6.96 | $8.03 | $6.90 | $6.31 | · | · | |
| Cash / Share | · | · | · | · | · | $2.58 | $3.76 | $2.61 | · | · | |
| Dividend / Share | $2.46 | $2.23 | $2.03 | $1.84 | $1.69 | $1.57 | $1.45 | $1.33 | $1.21 | $1.09 | |
| Dividend Paid / Share | $2.46 | $2.23 | $2.03 | $1.84 | $1.69 | $1.57 | $1.45 | $1.33 | $1.21 | $1.09 | |
| EPS (TTM) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.7% | 6.2% | 13.3% | 7.4% | 35.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.4% | 8.9% | 18.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 13.8% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 27.9% | 62.7% | 256.1% | -56.9% | -46.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 95.0% | 35.7% | -6.3% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 27.3% | 62.5% | 253.4% | -56.1% | -38.6% | · | · | · | · | · | |
| Net Income CAGR 3Y | 94.1% | 36.1% | -1.6% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 14.5% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | · | · | |
| Net Income TTM | $782M | $615M | $378M | $107M | $244M | $397M | $408M | $304M | · | · | |
| Market Cap | $21.63B | $22.28B | $22.23B | $18.87B | $24.19B | $16.26B | $11.89B | $10.82B | · | · | |
| Enterprise Value | · | · | · | · | · | $17.69B | $12.72B | $11.78B | · | · | |
| P/E | 27.9 | 36.6 | 59.0 | 178.8 | 97.5 | 41.1 | 29.4 | 36.1 | · | · | |
| P/S | 3.6 | 4.1 | 4.3 | 4.2 | 5.7 | 5.2 | 3.9 | 3.9 | · | · | |
| P/B | 3.0 | 3.4 | 3.5 | 3.1 | 3.7 | 4.2 | 3.5 | 3.4 | · | · | |
| P / Tangible Book | 15.8 | 34.1 | 198.2 | 155.6 | · | · | · | · | · | · | |
| P / Cash Flow | 16.1 | 19.4 | 22.8 | 24.9 | 35.3 | 23.6 | 20.1 | 20.1 | · | · | |
| P / FCF | 22.2 | 28.6 | 36.3 | 47.8 | 60.9 | 36.1 | 31.6 | 30.9 | · | · | |
| EV / EBITDA | · | · | · | · | · | 23.0 | 17.3 | 18.5 | · | · | |
| EV / FCF | · | · | · | · | · | 39.3 | 33.8 | 33.7 | · | · | |
| EV / Revenue | · | · | · | · | · | 5.7 | 4.2 | 4.2 | · | · | |
| Dividend Yield | 1.1% | 0.99% | 0.90% | 0.97% | 0.67% | 0.82% | 1.0% | 1.0% | · | · | |
| Earnings Yield | 3.6% | 2.7% | 1.7% | 0.56% | 1.0% | 2.4% | 3.4% | 2.8% | · | · | |
| Payout Ratio | 30.9% | 35.8% | 53.0% | 171.4% | 66.9% | 33.7% | 30.2% | 37.0% | · | · | |
| Annual Payout | $242M | $220M | $201M | $183M | $163M | $134M | $123M | $113M | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | $1.48B | $1.37B | $1.33B | $1.28B | $1.42B | $1.30B | $1.24B | $1.18B | $963M | $1.11B | $1.09B | |
| Cost of Revenue | $809M | $891M | $841M | $814M | $763M | $839M | $760M | $750M | $707M | $836M | $738M | $692M | $654M | $554M | $634M | $609M | |
| Gross Profit | $684M | $697M | $656M | $646M | $628M | $641M | $610M | $579M | $572M | $583M | $560M | $546M | $529M | $409M | $478M | $482M | |
| R&D Expense | $29M | $29M | $30M | $28M | $26M | $28M | $27M | $27M | $26M | $27M | $25M | $26M | $25M | $23M | $26M | $25M | |
| SG&A Expense | $370M | $352M | $352M | $350M | $354M | $334M | $336M | $329M | $336M | $309M | $308M | $328M | $307M | $128M | $305M | $323M | |
| Operating Expenses | $398M | $380M | $382M | $380M | $382M | $425M | $365M | $359M | $387M | $363M | $334M | $355M | $331M | $-339M | $331M | $839M | |
| Operating Income | $286M | $317M | $273M | $266M | $246M | $216M | $245M | $220M | $186M | $220M | $226M | $192M | $198M | $748M | $191M | $-306M | |
| Interest Expense | · | · | · | · | · | · | · | · | $30M | · | $39M | $37M | $32M | · | $29M | $26M | |
| Other Non-op | $3M | $3M | $3M | $2M | $2M | $4M | $2M | $1M | $1M | $6M | $2M | $1M | $1M | $321.0K | $-2M | $-524.0K | |
| Pretax Income | $274M | $304M | $258M | $253M | $232M | $197M | $229M | $195M | $175M | $191M | $190M | $156M | $167M | $718M | $172M | $159M | |
| Income Tax | $72M | $84M | $64M | $61M | $54M | $50M | $55M | $44M | $35M | $37M | $41M | $35M | $36M | $81M | $41M | $35M | |
| Net Income | $200M | $220M | $193M | $192M | $177M | $146M | $174M | $150M | $145M | $-1M | $141M | $115M | $124M | $187M | $124M | $-315M | |
| EPS (Basic) | · | $2.26 | $1.96 | $1.95 | $1.80 | $1.49 | $1.76 | $1.52 | $1.47 | $-0.01 | $1.42 | $1.17 | $1.25 | $1.87 | $1.24 | $-3.15 | |
| EPS (Diluted) | · | $2.24 | $1.96 | $1.94 | $1.79 | $1.48 | $1.75 | $1.51 | $1.46 | $-0.02 | $1.42 | $1.16 | $1.25 | $1.88 | $1.24 | $-3.15 | |
| Shares (Basic) | 97,600,000 | · | 98,200,000 | 98,400,000 | 98,400,000 | · | 98,500,000 | 98,700,000 | 98,900,000 | · | 98,802,000 | 98,785,000 | 98,708,000 | · | 99,716,000 | 99,969,000 | |
| Shares (Diluted) | 97,900,000 | · | 98,600,000 | 98,800,000 | 98,800,000 | · | 98,900,000 | 99,200,000 | 99,400,000 | · | 99,354,000 | 99,406,000 | 99,239,000 | · | 100,166,000 | 99,969,000 | |
| EBITDA | $410M | · | $273M | $266M | $365M | · | $245M | $220M | $298M | · | $216M | $186M | $327M | · | $191M | $-306M |
Bilans
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $482M | · | $424M | $319M | $280M | · | $155M | $172M | $198M | · | $196M | $214M | $209M | · | $259M | $258M | |
| Receivables | $1.01B | $1.09B | $991M | $947M | $947M | $1.04B | $915M | $923M | $893M | $1.01B | $964M | $940M | $888M | · | $823M | $780M | |
| Inventory | $712M | $632M | $674M | $658M | $641M | $581M | $650M | $689M | $699M | $675M | $856M | $821M | $769M | · | $694M | $645M | |
| Current Assets | $2.45B | $2.39B | $2.29B | $2.11B | $2.06B | $2.00B | $1.90B | $1.94B | $1.94B | $2.87B | $2.22B | $2.17B | $2.03B | · | $1.98B | $1.89B | |
| PP&E (Net) | $2.17B | $2.16B | $2.13B | $2.09B | $2.05B | $1.96B | $1.92B | $1.93B | $1.83B | $1.77B | $1.84B | $1.74B | $1.73B | · | $1.67B | $1.57B | |
| PP&E (Gross) | $4.17B | $4.11B | $4.05B | $3.96B | $3.87B | $3.69B | $3.61B | $3.60B | $3.44B | $3.34B | $3.41B | $3.25B | $3.20B | · | $3.06B | $2.90B | |
| Accum. Depreciation | $2.00B | $1.94B | $1.92B | $1.86B | $1.82B | $1.73B | $1.68B | $1.67B | $1.61B | $1.57B | $1.56B | $1.51B | $1.48B | · | $1.38B | $1.32B | |
| Goodwill | $4.19B | $4.19B | $4.23B | $4.22B | $4.22B | $4.10B | $4.04B | $4.15B | $4.06B | $4.07B | $4.11B | $4.04B | $3.89B | $3.88B | $3.85B | $3.71B | |
| Intangibles | $1.56B | $1.62B | $1.69B | $1.75B | $1.82B | $1.85B | $1.92B | $2.00B | $2.05B | $2.12B | $2.99B | $3.06B | $2.87B | · | $3.03B | $3.08B | |
| Other Non-current Assets | $215M | $211M | $94M | $88M | $89M | $83M | $68M | $60M | $63M | $66M | $77M | $73M | $80M | · | $80M | $72M | |
| Total Assets | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $10.11B | $11.06B | $11.44B | $11.28B | $10.78B | · | $10.80B | $10.49B | |
| Accounts Payable | $344M | $339M | $285M | $309M | $301M | $281M | $238M | $235M | $232M | $252M | $277M | $294M | $261M | · | $242M | $233M | |
| Accrued Liabilities | $420M | $402M | $405M | $360M | $371M | $368M | $335M | $307M | $287M | $320M | $318M | $307M | $333M | · | $303M | $304M | |
| Short-term Debt | $243M | $119M | $0 | $0 | $0 | $125M | $125M | $80M | $80M | $86M | $78M | $71M | $63M | · | $60M | $151M | |
| Current Liabilities | $1.28B | $1.15B | $922M | $889M | $927M | $1.02B | $891M | $805M | $834M | $931M | $914M | $873M | $887M | · | $796M | $873M | |
| Capital Leases | · | $120M | · | · | · | $125M | · | · | · | $146M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $75M | $72M | $67M | $64M | $64M | $62M | $73M | $74M | $72M | $72M | $78M | $77M | $77M | · | $73M | $76M | |
| Total Liabilities | $3.51B | $3.54B | $3.42B | $3.39B | $3.44B | $3.53B | $3.58B | $3.63B | $3.74B | $4.75B | $5.01B | $5.09B | $4.61B | · | $4.75B | $4.68B | |
| Long-term Debt | $1.65B | $1.81B | $1.90B | $1.90B | $1.90B | $1.92B | $2.04B | $2.16B | $2.24B | $3.12B | $3.23B | $3.37B | $2.86B | · | $3.00B | $2.87B | |
| Total Debt | $1.89B | · | $1.90B | $1.90B | $1.90B | · | $2.16B | $2.24B | $2.32B | · | $3.31B | $3.44B | $2.92B | · | $3.06B | $3.02B | |
| Common Stock | $4.18B | $4.28B | $4.34B | $4.36B | $4.43B | $4.42B | $4.40B | $4.49B | $4.50B | $4.54B | $4.53B | $4.52B | $4.50B | · | $4.63B | $4.71B | |
| Retained Earnings | $3.15B | $3.02B | $2.86B | $2.73B | $2.60B | $2.48B | $2.39B | $2.27B | $2.18B | $2.09B | $2.13B | $2.05B | $1.98B | · | $1.77B | $1.70B | |
| AOCI | $-127M | $-113M | $-43M | $-76M | $-70M | $-292M | $-374M | $-166M | $-323M | $-329M | $-253M | $-387M | $-311M | $-321M | $-364M | $-598M | |
| Stockholders' Equity | $7.21B | $7.18B | $7.15B | $7.01B | $6.96B | $6.60B | $6.42B | $6.59B | $6.35B | $6.30B | $6.42B | $6.18B | $6.17B | · | $6.04B | $5.80B | |
| Liabilities + Equity | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $10.11B | $11.06B | $11.44B | $11.28B | $10.78B | · | $10.80B | $10.49B | |
| Shares Outstanding | 97,500,000 | 97,800,000 | 98,100,000 | 98,100,000 | 98,500,000 | 98,300,000 | 98,245,000 | 98,708,000 | 98,799,000 | 98,900,000 | 98,808,000 | 98,789,000 | 98,781,000 | 98,629,000 | 99,401,000 | 99,868,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $124M | $123M | $122M | $122M | $119M | $122M | $126M | $115M | $113M | $134M | $141M | $152M | $138M | $142M | $138M | $134M | |
| Stock-based Comp | $13M | $13M | $16M | $21M | $12M | $10M | $15M | $21M | $12M | $9M | $15M | $21M | $12M | $9M | $9M | $12M | |
| Deferred Tax | $600.0K | $-17M | $-100.0K | $-100.0K | $0 | $-53M | $-2M | $21.0K | $-22M | $-131M | $808.0K | $-869.0K | $-445.0K | $-123M | $101.0K | $-68M | |
| Restructuring | · | $300.0K | $100.0K | $1M | $2M | $29M | $2M | $3M | $28M | $44M | $6.0K | $-23.0K | $19.0K | $359.0K | $38.0K | $62.0K | |
| Other Non-cash | $30M | · | · | · | $111M | · | · | · | $56M | · | · | · | $9M | · | · | · | |
| Operating Cash Flow | $367M | $335M | $298M | $288M | $420M | $261M | $333M | $251M | $304M | $255M | $291M | $146M | $281M | $216M | $206M | $104M | |
| CapEx | $88M | $90M | $99M | $86M | $94M | $71M | $89M | $102M | $108M | $91M | $119M | $83M | $67M | $71M | $92M | $83M | |
| Investing Cash Flow | $-108M | $-217M | $-98M | $-88M | $-108M | $-70M | $-124M | $-105M | $688M | $-96M | $-119M | $-606M | $-67M | $-78M | $-98M | $-98M | |
| Stock Repurchased | $116M | $74M | $50M | $100M | $11M | $200.0K | $100M | $46M | $64M | $359.0K | $2M | $489.0K | $9M | $155M | $84M | $45M | |
| Net Stock Activity | $-116M | · | · | · | $-11M | · | · | $-46M | $-64M | · | $-2M | $-489.0K | $-9M | · | $-84M | $-45M | |
| Dividends Paid | $61M | $62M | $62M | $62M | $56M | $56M | $56M | $56M | $51M | $51M | $51M | $51M | $46M | $47M | $47M | $47M | |
| Financing Cash Flow | $-214M | $-98M | $-98M | $-159M | $-213M | $-178M | $-214M | $-181M | $-999M | $-144M | $-198M | $470M | $-214M | $-192M | $-120M | $-45M | |
| Net Change in Cash | $43M | $16M | $104M | $40M | $108M | $16M | $-17M | $-26M | $-9M | $11M | $-18M | $5M | $257.0K | $-51M | $1M | $-58M | |
| Free Cash Flow | $280M | · | · | · | $326M | · | · | · | $196M | · | · | · | $215M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $171M | · | · | · | $189M | · | · | · |
Rentowność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.8% | · | 43.8% | 44.2% | 45.1% | · | 44.5% | 43.5% | 44.7% | · | 43.2% | 44.2% | 44.6% | · | 42.9% | 44.3% | |
| Operating Margin | 19.1% | · | 18.3% | 18.2% | 17.7% | · | 17.9% | 16.5% | 14.5% | · | 15.5% | 13.9% | 14.7% | · | 15.7% | -25.5% | |
| Net Margin | 13.4% | · | 12.9% | 13.1% | 12.8% | · | 12.7% | 11.3% | 11.4% | · | 10.1% | 8.6% | 9.6% | · | 10.2% | -26.3% | |
| Pretax Margin | 18.3% | · | 17.2% | 17.3% | 16.7% | · | 16.7% | 14.7% | 13.7% | · | 12.8% | 11.2% | 12.3% | · | 13.2% | -27.7% | |
| EBITDA Margin | 27.4% | · | 18.3% | 18.2% | 26.3% | · | 17.9% | 16.5% | 23.3% | · | 15.5% | 13.9% | 25.4% | · | 15.7% | -25.5% | |
| ROA | 1.9% | · | 1.9% | 1.9% | 1.7% | · | 1.6% | 1.4% | 1.4% | · | 1.3% | 1.1% | 1.1% | · | 1.1% | -2.8% | |
| ROE | 2.8% | · | 2.8% | 2.8% | 2.7% | · | 2.7% | 2.4% | 2.3% | · | 2.3% | 1.9% | 2.0% | · | 2.0% | -5.1% | |
| ROIC | 2.3% | · | 2.3% | 2.3% | 2.1% | · | 2.2% | 1.9% | 1.7% | · | 1.8% | 1.5% | 1.6% | · | 1.6% | -3.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | · | 2.5 | 2.4 | 2.2 | · | 2.1 | 2.4 | 2.3 | · | 2.4 | 2.5 | 2.3 | · | 2.5 | 2.2 | |
| Quick Ratio | 1.2 | · | 1.5 | 1.4 | 1.3 | · | 1.2 | 1.4 | 1.3 | · | 1.3 | 1.3 | 1.2 | · | 1.4 | 1.2 | |
| Debt / Equity | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| LT Debt / Equity | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 6.1 | · | 5.5 | 5.0 | 5.8 | · | 6.7 | -11.7 |
Efektywność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.1 | 1.1 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.6 | 1.5 | · | 1.5 | 1.4 | 1.4 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.6 |
Na akcję
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $73.91 | · | $72.93 | $71.45 | $70.63 | · | $65.31 | $66.80 | $64.32 | · | $64.93 | $62.54 | $62.44 | · | $60.75 | $58.10 | |
| Revenue / Share | $15.25 | · | $15.17 | $14.78 | $14.08 | · | $13.85 | $13.40 | $12.88 | · | $14.05 | $13.50 | $12.94 | · | $12.14 | · | |
| Cash Flow / Share | $3.75 | · | · | · | $4.25 | · | · | · | $3.06 | · | · | · | $2.83 | · | · | · | |
| Cash / Share | $4.95 | · | $4.32 | $3.25 | $2.84 | · | $1.58 | $1.74 | $2.01 | · | $1.98 | $2.16 | $2.11 | · | $2.61 | $2.59 | |
| Dividend / Share | $0.63 | $0.63 | $0.63 | $0.63 | $0.57 | $0.57 | $0.57 | $0.57 | $0.52 | $0.52 | $0.52 | $0.52 | $0.47 | $0.47 | $0.47 | $0.47 | |
| Dividend Paid / Share | $0.63 | $0.63 | $0.63 | $0.63 | $0.57 | $0.62 | $0.57 | $0.52 | $0.52 | $0.52 | $0.52 | $0.52 | $0.47 | $0.47 | $0.47 | $0.47 | |
| EPS (TTM) | $7.93 | · | $7.17 | $6.96 | $6.53 | · | $4.70 | $4.37 | $4.02 | · | $5.71 | $5.53 | $1.22 | · | $-0.20 | $-0.02 |
Wycena (TTM)
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.04B | · | $5.83B | $5.70B | $5.57B | · | $5.40B | $5.33B | $5.23B | · | $4.68B | $4.50B | $4.35B | · | $4.10B | $4.20B | |
| Net Income TTM | $805M | · | $708M | $688M | $647M | · | $467M | $435M | $400M | · | $567M | $550M | $119M | · | $-28M | $-8M | |
| Market Cap | $20.53B | · | $24.87B | $24.27B | $23.66B | · | $20.20B | $23.94B | $21.69B | · | $21.72B | $21.68B | $22.22B | · | $18.36B | $16.61B | |
| Enterprise Value | $21.94B | · | $26.35B | $25.85B | $25.29B | · | $22.20B | $26.00B | $23.81B | · | $24.84B | $24.90B | $24.94B | · | $21.16B | $19.37B | |
| P/E | 26.6 | · | 35.4 | 35.6 | 36.8 | · | 43.7 | 55.5 | 54.6 | · | 38.5 | 39.7 | 184.4 | · | -923.5 | -8314.0 | |
| P/S | 3.4 | · | 4.3 | 4.3 | 4.2 | · | 3.7 | 4.5 | 4.1 | · | 4.6 | 4.8 | 5.1 | · | 4.5 | 4.0 | |
| P/B | 2.8 | · | 3.5 | 3.5 | 3.4 | · | 3.1 | 3.6 | 3.4 | · | 3.4 | 3.5 | 3.6 | · | 3.0 | 2.9 | |
| P / Tangible Book | 14.1 | · | 20.2 | 23.2 | 25.8 | · | 45.0 | 54.6 | 87.2 | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.9 | · | · | · | 56.3 | · | · | · | 71.4 | · | · | · | 79.1 | · | · | · | |
| EV / Revenue | 3.6 | · | 4.5 | 4.5 | 4.5 | · | 4.1 | 4.9 | 4.5 | · | 5.3 | 5.5 | 5.7 | · | 5.2 | 4.6 | |
| Dividend Yield | 1.2% | · | 0.95% | 0.95% | 0.95% | · | 1.1% | 0.88% | 0.95% | · | 0.90% | 0.88% | 0.84% | · | 0.98% | 1.1% | |
| Earnings Yield | 3.8% | · | 2.8% | 2.8% | 2.7% | · | 2.3% | 1.8% | 1.8% | · | 2.6% | 2.5% | 0.54% | · | -0.11% | -0.01% | |
| Payout Ratio | 30.7% | · | · | · | 31.7% | · | · | · | 35.4% | · | · | · | 37.6% | · | · | · | |
| Annual Payout | $247M | · | $236M | $230M | $225M | · | $215M | $210M | $206M | · | $196M | $191M | $187M | · | $180M | $176M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Przychody | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B |
| Marża Brutto % | 44.2% | 44.0% | 43.2% | 43.6% | 44.0% |
| Marża Operacyjna % | 18.6% | 15.9% | 16.3% | 5.4% | 9.3% |
| Zysk netto | $782M | $615M | $378M | $107M | $244M |
| Rozwodniony EPS | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 |
| Wskaźnik bieżący | 2.1 | 2.0 | 3.1 | 2.3 | 2.0 |
| Wskaźnik Szybkości | 1.0 | 1.0 | 1.1 | 1.1 | 0.9 |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $972M | $778M | $613M | $395M | $397M |
Właściciele instytucjonalni (13F) 880 emitentów · $22.6B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 99 (-4 vs poprzedni kw.) | 99 (-23 vs poprzedni kw.) | 293 (+28 vs poprzedni kw.) | 306 (-34 vs poprzedni kw.) | +844K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3 114 882 353 | 12 286 535 | 13,80% | Akcje |
| BlackRock, Inc. | $1 857 414 656 | 8 820 889 | 8,23% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 349 102 196 | 6 406 906 | 5,98% | Akcje |
| STATE STREET CORP | $1 068 232 039 | 5 072 818 | 4,73% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 053 260 612 | 5 001 950 | 4,67% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $850 363 483 | 3 801 077 | 3,77% | Akcje |
| MORGAN STANLEY | $831 766 442 | 3 950 067 | 3,69% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $737 605 022 | 3 502 897 | 3,27% | Akcje |
| Orbis Allan Gray Ltd | $563 845 394 | 2 677 710 | 2,50% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $548 620 258 | 2 615 842 | 2,43% | Akcje |
| GENERATION INVESTMENT MANAGEMENT LLP | $480 246 578 | 2 280 698 | 2,13% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $463 300 325 | 2 200 220 | 2,05% | Akcje |
| JANUS HENDERSON GROUP PLC | $411 994 872 | 1 863 139 | 1,83% | Akcje |
| Select Equity Group, L.P. | $398 955 608 | 1 894 646 | 1,77% | Akcje |
| Invesco Ltd. | $380 328 852 | 1 806 187 | 1,69% | Akcje |
| Boston Partners | $315 497 209 | 1 498 334 | 1,40% | Akcje |
| GOLDMAN SACHS GROUP INC | $287 037 463 | 1 363 145 | 1,27% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $285 844 205 | 1 377 297 | 1,27% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $277 186 897 | 1 253 502 | 1,23% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $256 445 622 | 1 217 864 | 1,14% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $252 635 989 | 1 199 619 | 1,12% | Akcje |
| NORGES BANK | $251 035 869 | 1 192 173 | 1,11% | Akcje |
| NORTHERN TRUST CORP | $194 908 435 | 925 623 | 0,86% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $188 588 689 | 895 576 | 0,84% | Akcje |
| BANK OF AMERICA CORP /DE/ | $175 849 376 | 835 111 | 0,78% | Akcje |
| Legal & General Group Plc | $154 205 042 | 732 322 | 0,68% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $140 372 911 | 666 633 | 0,62% | Akcje |
| Findlay Park Partners LLP | $138 494 626 | 657 713 | 0,61% | Akcje |
| LONDON CO OF VIRGINIA | $135 103 429 | 641 604 | 0,60% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $127 005 820 | 603 153 | 0,56% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $115 966 163 | 550 725 | 0,51% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $112 852 811 | 510 346 | 0,50% | Akcje |
| DEUTSCHE BANK AG\ | $112 363 310 | 533 615 | 0,50% | Akcje |
| Amundi | $108 100 953 | 513 373 | 0,48% | Akcje |
| D. E. Shaw & Co., Inc. | $107 308 578 | 509 610 | 0,48% | Akcje |
| Bank of New York Mellon Corp | $106 001 338 | 503 402 | 0,47% | Akcje |
| JPMORGAN CHASE & CO | $104 490 709 | 490 014 | 0,46% | Akcje |
| LOCUST WOOD CAPITAL ADVISERS, LLC | $95 991 742 | 455 866 | 0,43% | Akcje |
| ROYAL LONDON ASSET MANAGEMENT LTD | $89 099 538 | 423 135 | 0,39% | Akcje |
| CITADEL ADVISORS LLC | $85 126 292 | 404 266 | 0,38% | Akcje |
| UBS Group AG | $83 596 501 | 397 001 | 0,37% | Akcje |
| Nuveen, LLC | $80 563 873 | 382 600 | 0,36% | Akcje |
| Sustainable Growth Advisers, LP | $79 013 655 | 375 237 | 0,35% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $78 455 434 | 372 586 | 0,35% | Akcje |
| Fenimore Asset Management Inc | $74 796 972 | 355 212 | 0,33% | Akcje |
| Williams Jones Wealth Management, LLC. | $70 114 973 | 332 977 | 0,31% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $66 103 000 | 313 924 | 0,29% | Akcje |
| Life Cycle Investment Partners Ltd | $63 595 720 | 302 017 | 0,28% | Akcje |
| Boston Trust Walden Corp | $63 265 756 | 300 450 | 0,28% | Akcje |
| Gotham Asset Management, LLC | $62 307 242 | 295 898 | 0,28% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| STERIS plc, Solar New US Holding Co, LLC, Crystal Merger Sub 1, LLC | 22 stycznia 2021 | · | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 31 insiderów · 16 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel A Carestio | President and CEO | 5 czerwca 2026 S | 63 647 | 0 | 3 | $-985 248 |
| Walter M Rosebrough Jr | President & CEO | 9 listopada 2020 S | 51 405 | 0 | 0 | $0 |
| Karen L Burton | Sr. Vice Pres., CFO | 4 czerwca 2026 F | 13 184 | 0 | 0 | $0 |
| Michael J Tokich | Sr. Vice Pres., CFO | 4 czerwca 2025 F | 43 891 | 0 | 0 | $0 |
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 15 czerwca 2026 S | 35 259 | 0 | 2 | $-4 274 068 |
| Kenneth E Kohler | SVP & GM, AST | 4 czerwca 2026 F | 11 332 | 0 | 0 | $0 |
| Julia Madsen | Sr. VP and GM, Life Sciences | 4 czerwca 2026 F | 12 257 | 0 | 2 | $-1 312 096 |
| Mary Clare Fraser | SVP & Chief HRO | 4 czerwca 2026 F | 13 716 | 0 | 0 | $0 |
| Renato Tamaro | V.P. & Corporate Treasurer | 4 czerwca 2026 F | 6 194 | 0 | 3 | $-1 297 039 |
| Lindsey Mcgowan | VP, Chf. Comp. & Quality Offc. | 2 czerwca 2026 A | 5 656 | 0 | 0 | $0 |
| Cary L Majors | SVP and President, Healthcare | 2 czerwca 2026 A | 17 338 | 0 | 0 | $0 |
| Andrew Xilas | SVP and GM, Dental | 31 maja 2024 F | 6 347 | 0 | 0 | $0 |
| Kathleen Bardwell | Sr.V. P. & C.C.O. | 28 czerwca 2019 M | 17 428 | 0 | 0 | $0 |
| Adrian Vincent Coward | Sr. V P, Healthcare Spec Serv | 31 maja 2019 A | 25 119 | 0 | 0 | $0 |
| Gulam Amjad Khan | Sr. V.P., Procedural Solutions | 31 maja 2019 A | 14 685 | 0 | 0 | $0 |
| Michiel Dezwaan | V.P., Human Resources & CHRO | 28 marca 2019 A | 30 | 0 | 0 | $0 |
| Mohsen Sohi | Dyrektor | 12 sierpnia 2026 M | 24 305 | 0 | 1 | $-956 795 |
| Pierre Boulud | Dyrektor | 10 sierpnia 2026 A | · | 0 | 0 | $0 |
| Louis Shapiro | Dyrektor | 10 sierpnia 2026 A | · | 0 | 0 | $0 |
| Esther M. Alegria | Dyrektor | 10 sierpnia 2026 A | · | 0 | 0 | $0 |
| Nirav R Shah | Dyrektor | 10 sierpnia 2026 A | 292 | 0 | 0 | $0 |
| Paul Edward Martin | Dyrektor | 10 sierpnia 2026 A | · | 0 | 0 | $0 |
| Christopher S Holland | Dyrektor | 10 sierpnia 2026 A | 582 | 0 | 0 | $0 |
| Cynthia L Feldmann | Dyrektor | 10 sierpnia 2026 A | 705 | 0 | 1 | $-734 877 |
| Richard C Breeden | Dyrektor | 2 czerwca 2026 M | 38 964 | 0 | 1 | $-310 284 |
| Richard Martin Steeves | Dyrektor | 8 sierpnia 2024 A | 0 | 0 | 0 | $0 |
| Jacqueline B Kosecoff | Dyrektor | 8 sierpnia 2024 A | 0 | 0 | 0 | $0 |
| David B Lewis | Dyrektor | 21 lipca 2021 M | 8 245 | 0 | 0 | $0 |
| Loyal W Wilson | Dyrektor | 4 czerwca 2019 M | 24 000 | 0 | 0 | $0 |
| Michael B Wood | Dyrektor | 16 maja 2019 S | 16 631 | 0 | 0 | $0 |
| Duncan K Nichol | Dyrektor | 28 marca 2019 A | · | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 107 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHI · iShares Trust | 3,14% | 468 870 SH | 11 września 2026 | Dziennie |
| POWA · Invesco Exchange-Traded Self-Indexe… | 1,88% | 14 818 SH | 2 października 2026 | Dziennie |
| NUMV · Nushares ETF Trust | 1,62% | 31 484 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,61% | 66 867 SH | 2 października 2026 | Dziennie |
| NUDV · Nushares ETF Trust | 0,95% | 2 081 NS | 31 lipca 2026 | N-PORT |
| SUSA · iShares Trust | 0,63% | 119 264 SH | 11 września 2026 | Dziennie |
| EVUS · iShares Trust | 0,49% | 8 778 SH | 11 września 2026 | Dziennie |
| NULV · Nushares ETF Trust | 0,40% | 38 341 NS | 31 lipca 2026 | N-PORT |
| IYH · iShares Trust | 0,34% | 57 333 SH | 11 września 2026 | Dziennie |
| VFMV · VANGUARD WELLINGTON FUND | 0,33% | 6 491 SH | 19 sierpnia 2026 | Dziennie |
| ESGU · iShares Trust | 0,32% | 272 491 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,30% | 294 875 SH | 19 sierpnia 2026 | Dziennie |
| IXJ · iShares Trust | 0,26% | 51 423 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,26% | 1 930 NS | 31 lipca 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0,23% | 375 677 SH | 19 sierpnia 2026 | Dziennie |
| ESLG · Strategy Shares | 0,22% | 225 NS | 31 lipca 2026 | N-PORT |
| IWS · iShares Trust | 0,20% | 146 233 SH | 11 września 2026 | Dziennie |
| VO · VANGUARD INDEX FUNDS | 0,20% | 2 125 301 SH | 19 sierpnia 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 907 382 SH | 2 października 2026 | Dziennie |
| SIZE · iShares Trust | 0,19% | 3 854 SH | 11 września 2026 | Dziennie |
| EUSA · iShares, Inc. | 0,18% | 16 470 SH | 11 września 2026 | Dziennie |
| VOE · VANGUARD INDEX FUNDS | 0,18% | 315 003 SH | 19 sierpnia 2026 | Dziennie |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,18% | 159 004 SH | 2 października 2026 | Dziennie |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,17% | 69 786 SH | 2 października 2026 | Dziennie |
| ESUM · Strategy Shares | 0,17% | 1 373 NS | 31 lipca 2026 | N-PORT |
| IMCV · iShares Trust | 0,17% | 9 269 SH | 11 września 2026 | Dziennie |
| IDHQ · Invesco Exchange-Traded Fund Trust … | 0,16% | 207 104 SH | 2 października 2026 | Dziennie |
| DFLV · Dimensional ETF Trust | 0,16% | 47 873 NS | 31 lipca 2026 | N-PORT |
| ESMV · iShares Trust | 0,16% | 59 SH | 11 września 2026 | Dziennie |
| IWR · iShares Trust | 0,15% | 400 582 SH | 11 września 2026 | Dziennie |
| ESLV · Strategy Shares | 0,15% | 93 NS | 31 lipca 2026 | N-PORT |
| IMCB · iShares Trust | 0,15% | 11 557 SH | 11 września 2026 | Dziennie |
| IMCG · iShares Trust | 0,12% | 23 208 SH | 11 września 2026 | Dziennie |
| XOEF · iShares Trust | 0,12% | 122 SH | 11 września 2026 | Dziennie |
| CATH · Global X Funds | 0,11% | 6 055 NS | 31 lipca 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,10% | 67 539 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3 558 SH | 2 października 2026 | Dziennie |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,09% | 130 000 | 2 października 2026 | Dziennie |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,09% | 554 067 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,09% | 2 140 NS | 31 lipca 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,08% | 931 689 SH | 19 sierpnia 2026 | Dziennie |
| PFM · Invesco Exchange-Traded Fund Trust | 0,08% | 2 780 SH | 2 października 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,07% | 10 863 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,07% | 154 755 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,07% | 16 155 SH | 2 października 2026 | Dziennie |
| CHRI · Global X Funds | 0,07% | 24 NS | 31 lipca 2026 | N-PORT |
| SUSL · iShares Trust | 0,06% | 3 429 SH | 11 września 2026 | Dziennie |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0,06% | 75 373 SH | 2 października 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 59 118 SH | 19 sierpnia 2026 | Dziennie |
| DSI · iShares Trust | 0,06% | 15 165 SH | 11 września 2026 | Dziennie |
| CRBN · iShares Trust | 0,06% | 3 088 SH | 11 września 2026 | Dziennie |
| IWD · iShares Trust | 0,06% | 217 252 SH | 11 września 2026 | Dziennie |
| DGRO · iShares Trust | 0,05% | 110 714 SH | 11 września 2026 | Dziennie |
| EGLE · Global X Funds | 0,05% | 5 NS | 31 lipca 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,05% | 4 010 SH | 2 października 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,04% | 23 890 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 4 327 NS | 31 lipca 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 1 998 SH | 2 października 2026 | Dziennie |
| TOPC · iShares Trust | 0,04% | 62 SH | 11 września 2026 | Dziennie |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 11 347 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,04% | 22 125 SH | 19 sierpnia 2026 | Dziennie |
| XYLG · Global X Funds | 0,04% | 112 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,04% | 5 420 NS | 31 lipca 2026 | N-PORT |
| XVV · iShares Trust | 0,04% | 1 132 SH | 11 września 2026 | Dziennie |
| VOTE · TCW ETF Trust | 0,03% | 1 670 NS | 31 lipca 2026 | N-PORT |
| IVE · iShares Trust | 0,03% | 80 778 SH | 11 września 2026 | Dziennie |
| ILCV · iShares Trust | 0,03% | 2 187 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 15 958 SH | 2 października 2026 | Dziennie |
| XRMI · Global X Funds | 0,03% | 74 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,03% | 30 498 NS | 31 lipca 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 42 821 SH | 11 września 2026 | Dziennie |
| SPUU · Direxion Shares ETF Trust | 0,03% | 370 NS | 31 lipca 2026 | N-PORT |
| XCLR · Global X Funds | 0,03% | 5 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,03% | 1 236 184 SH | 11 września 2026 | Dziennie |
| ILCB · iShares Trust | 0,03% | 1 913 SH | 11 września 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,03% | 583 SH | 2 października 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,03% | 16 872 SH | 2 października 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,03% | 13 984 SH | 2 października 2026 | Dziennie |
| VOO · VANGUARD INDEX FUNDS | 0,03% | 2 548 531 SH | 19 sierpnia 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,03% | 114 510 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,03% | 3 115 102 SH | 19 sierpnia 2026 | Dziennie |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,03% | 36 417 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,03% | 16 114 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,03% | 8 227 SH | 19 sierpnia 2026 | Dziennie |
| IYY · iShares Trust | 0,03% | 4 226 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,03% | 67 954 SH | 11 września 2026 | Dziennie |
| IVW · iShares Trust | 0,03% | 105 352 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,03% | 128 261 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,03% | 26 980 SH | 11 września 2026 | Dziennie |
| XTR · Global X Funds | 0,03% | 6 NS | 31 lipca 2026 | N-PORT |
| ILCG · iShares Trust | 0,03% | 4 117 SH | 10 września 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,03% | 683 NS | 31 lipca 2026 | N-PORT |
| IUSG · iShares Trust | 0,03% | 42 749 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,03% | 78 SH | 2 października 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,03% | 7 670 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,02% | 271 SH | 11 września 2026 | Dziennie |
| URTH · iShares, Inc. | 0,02% | 9 040 SH | 11 września 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 83 634 SH | 19 sierpnia 2026 | Dziennie |
| ACWI · iShares Trust | 0,02% | 30 640 SH | 11 września 2026 | Dziennie |
| PZA · Invesco Exchange-Traded Fund Trust … | 0,02% | 795 000 | 2 października 2026 | Dziennie |
| DFVX · Dimensional ETF Trust | 0,00% | 82 NS | 31 lipca 2026 | N-PORT |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14 lipca 2026 | Dziennie |
STE Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
8 analityków · 2026-10-02Średnia cel $263.12 +26,2%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.